Latest Listings And Ipos News

New Frontier Minerals has secured regulatory approval to launch its first reverse circulation drilling campaign at the Harts Range Heavy Rare Earth and Niobium Project, while also preparing for a US OTCQB listing to broaden investor reach.

Mandrake Resources has signed a term sheet with DISA Technologies to explore recovering uranium and critical minerals from abandoned mine waste in Utah, leveraging a unique US regulatory license and strong government backing.

8I Holdings Limited has reported a remarkable 255% surge in net profit for the half-year ending September 2025, yet it has chosen not to declare any dividends. Investors are left weighing strong gains against cautious capital management.

Perpetual Credit Income Trust (PCI) has announced a $267 million entitlement and shortfall offer priced at $1.10 per unit, aiming to bolster its investment capacity in Australian credit markets. The offer presents a 9.1% discount to recent trading prices and is designed to enhance liquidity and scale for existing and new investors.

Invex Therapeutics Ltd has been suspended from trading on the ASX due to a failure to maintain the minimum number of directors required by law. The suspension will remain until the company rectifies its governance structure and complies with listing rules.

Gladiator Resources has provided detailed clarifications to the ASX regarding its agreement with Apex USA Resources LLC for rare earth tenements in California, highlighting ongoing disputes and incomplete project milestones.

TT Investments has launched an unconditional $0.31 per security takeover bid for 360 Capital Group, aiming to delist the company from the ASX. The Independent Board Committee recommends acceptance amid significant premiums and looming governance changes.

Tungsten Mining has secured a listing on the US OTCQB exchange and launched a Denver office, marking a strategic push into North America’s critical minerals market.

Alliance Nickel’s binding offtake agreement with Stellantis is terminated due to missed milestones amid tough nickel market conditions, yet renegotiation talks signal ongoing partnership potential.

Mayne Pharma’s acquisition by Cosette Pharmaceuticals faces a regulatory delay as the Foreign Investment Review Board extends its approval deadline, pushing the court hearing to mid-November.

Eagle Mountain Mining has requested a voluntary suspension of its ASX-listed securities pending a capital raising announcement, with trading expected to resume by 11 November 2025.

Light & Wonder, Inc. is set to extend its substantial share repurchase program to include its ASX-listed CHESS Depositary Interests starting November 7, 2025, coinciding with its planned Nasdaq delisting.